Close Menu
The Reporters
  • Home
  • News
  • Politics
  • Crime
  • Health
  • Features
  • Economy
  • Environment
  • Entertainment
  • Business
  • Technology
  • Education
  • Sports
  • Tourism
  • Judiciary
  • Judiciary
  • Foreign
  • Agriculture
  • Religion
  • Weather
  • Banking
  • Labour
  • Faith
  • Advertisment
Facebook X (Twitter) Instagram
  • Home
  • Lifestyle
  • Travel
  • Buy Now
Facebook X (Twitter) Instagram Pinterest Vimeo
The Reporters
  • Home
  • News
  • Politics
  • Crime
  • Health
  • Features
  • Economy
  • Environment
  • Entertainment
  • Business
  • Technology
  • Education
  • Sports
  • Tourism
  • Judiciary
  • Judiciary
  • Foreign
  • Agriculture
  • Religion
  • Weather
  • Banking
  • Labour
  • Faith
  • Advertisment
Subscribe
The Reporters
Health

Stop using Weight Rapid Loss Capsule,NAFDAC boss cautions public

AdminBy AdminJanuary 24, 2023Updated:January 24, 2023No Comments2 Mins Read
Spread the love


Prof.Mojisola Adeyeye,DG.NAFDAC.
Photo credit:NAFDAC.

Agency news.

The National Agency for Food and Drugs Administration and Control (NAFDAC) has cautioned Nigerians against the use of the drug — Weight Rapid Loss Capsule.

The caution is contained in an alert with No. 049/2022, signed by NAFDAC’s Director-General, Prof. Mojisola Adeyeye, issued to the News Agency of Nigeria (NAN) on Sunday in Abuja.

Adeyeye stated that the drug has been found to have potential to cause cancer.

The NAFDAC boss added that result of laboratory analysis showed that the drug, manufactured by Ingi Oman, contain banned substance “phenolphthalein”, which the U.S. Food and Drug Administration recognised as unsafe.

She added that the capsule, being marketed as “the most effective weight loss supplement” and sold through social media platforms like Instagram, also contain microbial growth above permissible limits.

She stated that “phenolphthalein has been found to be toxic to genes, as it can cause damage or mutations in the DNA. Studies have also shown its potential carcinogenic risks.

“NAFDAC implores consumers to stop the purchase and use of the product.

“Members of the public in possession of the product should discontinue use or sale, and submit stock to the nearest NAFDAC office.”

Adeyeye encouraged healthcare professionals and consumers to report any adverse effect experienced with the use of the product to the nearest NAFDAC office.

Consumers are also advised to report adverse effect via pharmacovigilance@nafdac.gov.ng or E-reporting platforms available at www.nafdac.gov.ng.

The director-general urged the public to also report any incident concerning the use of the drug via the Med-safety application, which can be downloaded on android and IOS stores.

Visited 5 times, 1 visit(s) today
Previous ArticleNigeria hosts Regional Digital Economy Conference
Next Article Burial programme for Mrs. Helen Osheiza Chukwu
Admin

Related Posts

He Survived a Mental Health Crisis Alone—Then Created a Framework to Help the World Heal

May 19, 2025

As enrollment of nurses peaks at 115,000, Nigeria ready to outsource medical personnel to the world – TMV

May 10, 2025

Foundation Provides Free Eye Care to 1,000 Nigerians, including 200 in Niger

May 3, 2025

Leave A Reply Cancel Reply

Recent Posts
  • Customs Seeks Stronger Synergy with Security Agencies to Secure Maritime Domain
  • Senator Karimi Advocates Constitutional Amendment for Establishment of State Police
  • Forum declares Etsu Lokoja an impostor, cautions public against relating with him
  • Photo speak:The potential entrepreneur
  • IBB Mourns Mokwa Flood Victims, Pledges Support for Niger
© 2025 The Reporters. Designed by Domo Tech Media .
  • Home
  • Contact Us
  • About Us
  • Posts
  • Privacy Policy

Type above and press Enter to search. Press Esc to cancel.